A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis

Exclusion Criteria

• •Subject has non-plaque psoriasis at Screening and Day 1.
• •Subject has a history of skin disease or presence of skin condition that, in the opinion of the Investigator, would interfere with the study assessments at Screening and Day 1.
• •Subject has used any topical therapy to treat psoriasis within 2 weeks prior to Day 1.